{"url_path":"/sec/imdx/8-k/2026-05-13/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-022721-index.html","accession_number":"0001493152-26-022721","cik":"0001642380","ticker":"IMDX","issuer_name":"Insight Molecular Diagnostics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-022721-index.html","primary_entity_key":"0001642380","primary_entity_name":"Insight Molecular Diagnostics Inc."},"word_count":301,"has_tables":true,"body_markdown":"false\n0001642380\n\n0001642380\n\n2026-05-13\n2026-05-13\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM\n8-K**\n\n \n\nCurrent\nReport\n\nPursuant\nto Section 13 or 15(d) of the\n\nSecurities\nExchange Act of 1934\n\n \n\nDate\nof Report (Date of earliest event reported): **May 13, 2026**\n\n \n\n**Insight\nMolecular Diagnostics Inc.**\n\n(Exact\nname of Registrant as specified in its charter)\n\n \n\n**California**\n \n**1-37648**\n \n**27-1041563**\n\n(State\nor other jurisdiction\n\nof\nincorporation)\n\n \n\n(Commission\n\nFile\nNo.)\n\n \n\n(IRS\nEmployer\n\nIdentification\nNo.)\n\n \n\n**2\nInternational Plaza Dr., Suite 510**\n\n**Nashville,\nTennessee 37217**\n\n(Address\nof principal executive offices) (Zip code)\n\n \n\n**(615)\n255-8880**\n\nRegistrant’s\ntelephone number, including area code\n\n \n\nCheck\nthe appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under\nany of the following provisions:\n\n \n\n☐\nWritten communications\npursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n \n\n☐\nSoliciting material pursuant\nto Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement communications\npursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement communications\npursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities\nRegistered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each\nclass\n \nTrading Symbol(s)\n \nName of each\nexchange on which registered\n\nCommon stock, no par value\n \nIMDX\n \nThe Nasdaq Stock Market\nLLC\n\n \n\nIndicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405\nof this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging\ngrowth company ☐\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}